The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human (Q45110128)
Jump to navigation
Jump to search
scientific article published in November 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human |
scientific article published in November 2004 |
Statements
1 reference
The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human (English)
1 reference
Yunhui Wu
1 reference
Alice Loper
1 reference
Elizabeth Landis
1 reference
Lisa Hettrick
1 reference
Linda Novak
1 reference
Kari Lynn
1 reference
Cindy Chen
1 reference
Karen Thompson
1 reference
Ray Higgins
1 reference
Udit Batra
1 reference
Suhas Shelukar
1 reference
Gloria Kwei
1 reference
David Storey
1 reference
1 November 2004
1 reference
1 reference
285
1 reference
1-2
1 reference
135-146
1 reference
Identifiers
1 reference
1 reference